ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors

More about Open Access at the Crick


Christopher Abbosh and Charles Swanton discuss circulating tumor DNA as a potential biomarker for neoadjuvant treatment response in solid tumors.

Journal details

Journal PLOS Medicine
Volume 18
Issue number 10
Pages e1003771
Available online
Publication date